Neuroendocrine Tumors: Targeted Therapies – Update from NET Specialist Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center – August 2021

Background.  For those who want a quick run through of Neuroendocrine Tumors from diagnosis to selection of treatment, about the treatments themselves plus what is the Future Directions in the Management of Neuroendocrine Tumors.  There are 8 episodes, and each is around 3-5 minutes long. I personally found them very useful and in a language understandable to patients. 

Great job by OncLive and Dr Reidy-Lagunes! 

Diane Reidy-Lagunes, MD, provides an overview of neuroendocrine tumors, along with specific considerations for optimal diagnosis and prognostication. 

Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors (onclive.com)

Expert insight on the pathogenesis of neuroendocrine tumors and the best use of molecular testing to inform treatment decisions.

Neuroendocrine Tumor Pathogenesis and Molecular Testing (onclive.com)

Standard treatment pathways for patients with neuroendocrine tumors involving systemic therapy, surgery, and radiation.

An Overview of Treatment Approaches for Neuroendocrine Tumors (onclive.com)

A detailed explanation on how disease and patient factors inform selection from the treatment armamentarium for neuroendocrine tumors.

Neuroendocrine Tumors: Factors That Inform Therapy Selection (onclive.com)

Diane Reidy-Lagunes, MD, outlines goals of therapy and selection of systemic therapy for patients with neuroendocrine tumors.

Systemic Therapy for Advanced Neuroendocrine Tumors (onclive.com)

Expert reflections on VEGF-targeted therapy’s role in the treatment of patients with neuroendocrine tumors.

Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies (onclive.com)

Considerations for use of surufatinib in patients with neuroendocrine tumors in light of the SANET-p and SANET-ep clinical trials.

Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib (onclive.com)

Looking toward the future management of neuroendocrine tumors, Diane Reidy-Lagunes, MD, shares insight on possible therapy evolutions and ongoing unmet needs.

Future Directions in the Management of Neuroendocrine Tumors (onclive.com)

Most of this is pretty standard knowledge across the NET Specialist community.  One thing I would add is that Dr Reidy-Lagunes talked in at least one of the videos about her own approach to treating NET patients and this may differ in other NET centers.

I hope you enjoyed watching these short but very informative videos? 

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email

Subscribe to my newsletter

Thanks for reading.

Ronny


I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’

Sign up for my newsletters –  Click Here 

Disclaimer

My Diagnosis and Treatment History

Follow me on twitter

Check out my Podcast Interview (click and press play)

Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!

wego-blog-2018-winner

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 

I love comments - feel free!

%d bloggers like this: